A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral ZYGK1 in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01472809
Recruitment Status : Suspended (Not achieved the objective till 4 mg single dose)
First Posted : November 17, 2011
Last Update Posted : November 24, 2015
Information provided by (Responsible Party):
Cadila Healthcare Limited

No Study Results Posted on for this Study
  Recruitment Status : Suspended
  Primary Completion Date : December 2012
  Study Completion Date : No date given